(Total Views: 143)
Posted On: 10/13/2023 4:51:12 PM
Post# of 16

$RHHBY News Article - Late-Breaking Data for Genentech's BTK Inhibitor Fenebrutinib Show Brain Penetration and Significant Reduction in Lesions in Patients With Relapsing Multiple Sclerosis https://marketwirenews.com/news-releases/late...49372.html


My Twitter: WhyteStocks